Format
Sort by
Items per page

Send to

Choose Destination

Links from NLM Catalog

Items: 1 to 20 of 678

1.

Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives.

Bennett M, Paice JA, Wallace M.

Am Soc Clin Oncol Educ Book. 2017;37:705-713. doi: 10.14694/EDBK_180469.

2.

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.

Garralda E, Dienstmann R, Tabernero J.

Am Soc Clin Oncol Educ Book. 2017;37:210-215. doi: 10.14694/EDBK_180460.

3.

European/U.S. Comparison and Contrasts in Ovarian Cancer Screening and Prevention in a High-Risk Population.

Mourits MJ, de Bock GH.

Am Soc Clin Oncol Educ Book. 2017;37:124-127. doi: 10.14694/EDBK_180330.

4.

Adoptive T-Cell Therapy for Solid Tumors.

Yeku O, Li X, Brentjens RJ.

Am Soc Clin Oncol Educ Book. 2017;37:193-204. doi: 10.14694/EDBK_180328.

5.

Social Media for Networking, Professional Development, and Patient Engagement.

Markham MJ, Gentile D, Graham DL.

Am Soc Clin Oncol Educ Book. 2017;37:782-787. doi: 10.14694/EDBK_180077.

6.

Caring for the Older Population With Advanced Lung Cancer.

Presley CJ, Reynolds CH, Langer CJ.

Am Soc Clin Oncol Educ Book. 2017;37:587-596. doi: 10.14694/EDBK_179850.

7.

Challenges in Opening and Enrolling Patients in Clinical Trials.

Vose JM, Chuk MK, Giles F.

Am Soc Clin Oncol Educ Book. 2017;37:139-143. doi: 10.14694/EDBK_179807.

8.

Strategies to Maximize Patient Participation in Clinical Trials.

Rubin EH, Scroggins MJ, Goldberg KB, Beaver JA.

Am Soc Clin Oncol Educ Book. 2017;37:216-221. doi: 10.14694/EDBK_179803.

9.

Wedge Resection Versus Anatomic Resection: Extent of Surgical Resection for Stage I and II Lung Cancer.

Asamura H, Aokage K, Yotsukura M.

Am Soc Clin Oncol Educ Book. 2017;37:426-433. doi: 10.14694/EDBK_179730.

10.

Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment.

Gnant M, Van Poznak C, Schnipper L.

Am Soc Clin Oncol Educ Book. 2017;37:116-122. doi: 10.14694/EDBK_177357.

11.

Managing Resistance to EFGR- and ALK-Targeted Therapies.

Lovly CM, Iyengar P, Gainor JF.

Am Soc Clin Oncol Educ Book. 2017;37:607-618. doi: 10.14694/EDBK_176251.

12.

mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice.

Pennell NA, Dicker AP, Tran C, Jim HSL, Schwartz DL, Stepanski EJ.

Am Soc Clin Oncol Educ Book. 2017;37:144-154. doi: 10.14694/EDBK_176093.

13.

Chronic Myeloid Leukemia: What Every Practitioner Needs to Know in 2017.

Khoury HJ, Williams LA, Atallah E, Hehlmann R.

Am Soc Clin Oncol Educ Book. 2017;37:468-479. doi: 10.14694/EDBK_175712.

14.

Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.

Atreya CE, Yaeger R, Chu E.

Am Soc Clin Oncol Educ Book. 2017;37:246-256. doi: 10.14694/EDBK_175679.

15.

Addressing the Survivorship Care Needs of Patients Receiving Extended Cancer Treatment.

Jacobsen PB, Nipp RD, Ganz PA.

Am Soc Clin Oncol Educ Book. 2017;37:674-683. doi: 10.14694/EDBK_175673.

16.

Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation.

Hodgson D, van Leeuwen F, Ng A, Morton L, Henderson TO.

Am Soc Clin Oncol Educ Book. 2017;37:736-745. doi: 10.14694/EDBK_175668.

17.

Endometrial Cancer: Is This a New Disease?

Moore K, Brewer MA.

Am Soc Clin Oncol Educ Book. 2017;37:435-442. doi: 10.14694/EDBK_175666.

18.

Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer.

McCleary NJ, Benson AB 3rd, Dienstmann R.

Am Soc Clin Oncol Educ Book. 2017;37:232-245. doi: 10.14694/EDBK_175660.

19.

Collaborating With Advanced Practice Providers: Impact and Opportunity.

Hylton HM, Smith GL.

Am Soc Clin Oncol Educ Book. 2017;37:e1-e7. doi: 10.14694/EDBK_175654.

20.

Novel Targeted Agents and Immunotherapy in Breast Cancer.

Mayer IA, Dent R, Tan T, Savas P, Loi S.

Am Soc Clin Oncol Educ Book. 2017;37:65-75. doi: 10.14694/EDBK_175631.

Supplemental Content

Support Center